Amy Kluesner

• Represented a medspa owner in the sale of practice in New York City  
• Represented a fitness gym owner and certain healthcare providers in the creation of a management services organization (MSO) in relation to nutrition programs and GLP1 weight loss medication 
• Represented a dental support organization in acquisition of dental practices in the Southeast and ongoing corporate advice 
• Represented a healthcare software company with regard to general corporate matters 
• Represented buyer in purchase of home health organization with multiple locations in Georgia
• Represented a dental support organization (DSO) in multiple stock and asset acquisitions in various states throughout the Southeast, as well as ongoing advisory with regard to real estate leases, vendor services contracts, licensure, and regulatory matters
• Represented a physical therapy portfolio company in multiple stock and asset acquisitions in various states, as well as ongoing general corporate advisory with regard to real estate leases, commercial contracts, and under arrangements with hospitals and health systems 
• Represented a hospice and home health service provider backed by private equity in its acquisition of a NYSE-listed home health and hospice business for approximately $80 million
• Represented a privately held pharmaceutical company in its acquisition of a publicly traded pharmaceutical company in a tender offer and subsequent merger for approximately $475 million
• Represented a multi-state specialty pharmacy in its acquisition of all of the equity interests of another specialty pharmacy, as well as ongoing general corporate matters
• Represented a global medical product and device company in the sale of a subsidiary
• Represented a nonprofit hospital, owned by a hospital authority, in its purchase of a regional medical center out of bankruptcy for approximately $70 million
• Represented one of the nation’s largest publicly-traded home health companies in a system-wide joint venture with another health system valued at over $200 million
• Represented a nonprofit health system in its negotiation of an affiliation with one of the nation’s leading providers of health care services in a transaction valued at approximately $500 million
• Represented a NYSE-listed medical technology company in the sale of its surgical and infection prevention business to another publicly-traded company for approximately $700 million
• Represented a diversified healthcare services corporation in its disposition of two hospitals 
• Represented a large developer of transitional health care properties in various private equity deals
• Represented a private equity firm in various transactions, including the following closed matters:
  
  • Disposition of home health and hospice portfolio company to a private equity firm
  • Acquisition of a manufacturer of synthetic building products  
• Represented a portfolio company that is an operator of behavioral health care treatment centers and programs in various acquisitions of other behavioral health companies
• Represented a NYSE-listed consumer healthcare company in its SEC reporting and disclosure, and corporate governance matters
• Represented a NYSE-listed medical technology company in its SEC reporting and disclosure, and corporate governance matters
• Represented a biotech company in its Series A financing and general corporate matters
• Represented a major clinical staffing company in various corporate, securities, and M&A matters   
• Represented a nonprofit entity in its establishment of a needs-based pharmacy (pro bono) 

• American Health Law Association’s 2024 Health Care Transactions Conference, Presenter for Legal Ethics CLE titled, “Ethical Principles for In-House Counsel: Practical Guidance for Doing What is Right and Staying Employed,” Nashville, Tennessee (April 2024) 
• ABA Business Law Section Spring Meeting, Program Chair and Moderator for CLE titled, “Making it Rain: Business Development for Young Lawyers,” San Francisco, California (April 2015)
• ABA Business Law Section Fall Meeting, Panelist for CLE titled, “Enterprise Risk Management for Nonprofit Organizations: Meeting Challenges to Tax Exempt Status,” Chicago, Illinois (September 2014)

Harvard Journal of Sports and Entertainment Law, “And They're Off: Eliminating Drug Use in Thoroughbred Racing,” July 1, 2012